Biotechnology China’s WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in human vaccine Contract Development and Manufacturing Organization (CDMO) business, is to invest $240 million in building a new vaccine manufacturing facility in Ireland. 23 November 2019